Physician CME

Retina Resource

30th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma - Learning Hub

Stay up to date with the latest advances in hematologic malignancies throug…

23rd Annual School of Breast Oncology® Curriculum

Joyce O’Shaughnessy, MD

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways from Limited-Stage Through Relapsed Disease

Webinar Series

Project ECHO®: From Evidence to Action: Integrating New ADC Approaches to Optimize Treatment Sequencing in mTNBC

Tiffany A. Traina, MD, FASCO; Nour Abuhadra, MD; Joshua Z. Drago, MD, MS; Y…

Annual Hematology Meeting Preceding the 68th ASH Annual Meeting and Exposition

December 11, 2026

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Kentucky

Lori A. Leslie, MD; Sushil Bhardwaj, MD, FACP

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | Rhode Island Oncology Society

Aditya Bardia, MD, MPH, FASCO; Benjamin Scheier, MD

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | Arkansas Association of Cancer Professionals

Kamel Abou Hussein, MD; Yelda Nouri, MD

The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing

Seth A. Wander, MD, PhD; Reshma L. Mahtani, DO; Shanu Modi, MD; Joyce O’Sha…

𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne…

Advancing Targeted Therapy in HR+/HER2– Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies Into Practice

Joyce O’Shaughnessy, MD; Sarat Chandarlapaty, MD, PhD; Mitchell Elliott, MD…

27th Annual International Lung Cancer Congress®

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FA…

Evaluating Clinical Trials in Retinal Disease: Essentials for Eyecare Professionals

Medical Crossfire®: BPDCN in 2026—Expert Perspectives on Diagnosis, Frontline Therapy, and the Evolving CD123-Directed Pipeline

Andrew A. Lane, MD, PhD; Marlise Luskin, MD, MSCE; Kendra Sweet, MD

Introducing Novel Treatment Paradigms for Metastatic TNBC

Aditya Bardia, MD, MPH, FASCO; Alexis LeVee, MD

Key Considerations for Health Equity and Patient-Centered Care in TNBC

Aditya Bardia, MD, MPH, FASCO; Kathryn E. Post, PhD, ANP-BC

Current Approaches and Future Directions for Early-Stage TNBC

Nour Abuhadra, MD; Antonio Giordano, MD, PhD

From Trials to the Clinic ‒ Incorporating New Advances in Metastatic TNBC

William J. Gradishar, MD, FASCO, FACP; Kamel Abou Hussein, MD

Rapid Reviews in Retina™: 2026 Bimonthly Updates: Part Two — Safety

Hong-Uyen Hua, MD

25th Annual International Congress on the Future of Breast Cancer® West

Sara A. Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD

Clinical Consultations: Comprehensive Management of Obesity as a Chronic Disease: New and Emerging Strategies

Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FAMWA, FTOS; Rob…

“D” is for Diagnosis™: Seeking the Cause of Abdominal Pain

Brendan McGuire, MD, MS; Herbert Bonkovsky, MD

Expert Illustrations & Commentaries™: Outlining the Role of BTK inhibitors in Multiple Sclerosis

Stephen Krieger, MD, FAAN; Enrique Alvarez, MD, PhD

Optimizing NSCLC Readiness in the Era of TROP2-Targeted ADCs: Frontline Combinations, CNS Disease, and Toxicity Differentiation

Solange Peters, MD, PhD; Myung-Ju Ahn, MD, PhD; Benjamin P. Levy, MD; Steph…

Advancing Access to High-Quality, Biomarker-Guided Care for All Patients With mNSCLC

Narjust Florez, MD, FASCO; Darren Luon, PharmD, BCOP; Dipesh Uprety, MD; Co…

Community Practice Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma

Geoffrey Ku, MD; Sunnie S. Kim, MD

Satellite Symposia at the Annual Radiation Oncology Meeting

September 27-28, 2026

25th Annual International Congress on the Future of Breast Cancer® East

Joyce O’Shaughnessy, MD

Project ECHO®: Extending the Impact of CAR T—Practical Approaches to Long-Term Care in the Community

Jesús G. Berdeja, MD; Nicholas Barkemeyer, PA-C, MPAS; Michael Byrne, DO, F…

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | Wisconsin Association of Hematology and Oncology

Kurt C. Demel, MD, MBA; Sara A. Hurvitz, MD, FACP

Medical Crossfire®: ADCs and Bispecifics in Lung Cancer – Hype, Hope, or a New Standard of Care?

September 12, 2026

Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

August 20, 2026

Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma – Arizona

Syma Iqbal, MD; Benjamin Scheier, MD

10th Annual Live Medical Crossfire®: Hematologic Malignancies

Barbara Pro, MD; Saad Z. Usmani, MD, MBA, FACP, FASCO; Amer Zeidan, MD

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

October 16, 2026

Project ECHO®: Navigating CRS and ICANS Related to CAR T-Cell Therapy: Prevention, Grading, and Management in Practice

Jesús G. Berdeja, MD; Michael Byrne, DO, FACP; Kyle T. Roberts, PA-C

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Nevada

Krish Patel, MD; Matthew Ulrickson, MD

Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

August 24, 2026

Project ECHO®: Building Bridges in CAR T Care: Collaborative Pathways to Improve Patient Access and Navigate Referrals

Jesús G. Berdeja, MD; Michael Byrne, DO, FACP; Katie Marcucci, DMSc, PA-C, …

Oncology Town Hall: Insights Reshaping How We Treat MPNs From the 2026 Summer Oncology Meetings

John O. Mascarenhas, MD; Claire Harrison, MD, DM, FRCP, FRCPath; Raajit Ram…

Project ECHO®: Advancing Care in Metastatic TNBC Through PD-L1–Informed Novel Frontline ADC Strategies

Webinar Series

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2– Metastatic Breast Cancer | Missouri Oncology Society

Sara A. Hurvitz, MD, FACP; Shaina Rozell, MD, MPH

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2– Metastatic Breast Cancer | Louisiana Oncology Society

Kamel Abou Hussein, MD

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Montana/Wyoming

Lori A. Leslie, MD; Jack W. Erter III, MD, MMHC

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – North Carolina

Krish Patel, MD; Tara Graff, DO, MS

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Washington

Krish Patel, MD; Girish Kunapareddy, MD